Implementation Observations Tool

by Maya Labat | Oct 18, 2023

Pre-Implementation Tool

by Maya Labat | Oct 18, 2023

Boost Event: Assessing Facility Risk for Influenza, COVID-19 and Other Respiratory Pathogens

by Maya Labat | Oct 18, 2023

Fentanyl and Emerging Trends

by Maya Labat | Oct 13, 2023

This webinar offers a comprehensive overview of fentanyl, delineating its dual identity as a legitimate medication and a hazardous illicit substance. It methodically illuminates fentanyl’s pivotal role in overdoses, providing clear guidelines on precautionary measures...

Management of Patients on MOUD – Key Takeaways and Series Wrap Up

by Maya Labat | Oct 13, 2023

More than 1 million of Medicare beneficiaries had a diagnosis of opioid use disorder in 2020. However, fewer than 1 in 5 Medicare beneficiaries with an opioid use disorder diagnosis received medication to treat this condition. In addition, the number of patients who...